Skip to content
#

cancer-immunotherapy

Here are 5 public repositories matching this topic...

Language: All
Filter by language

Glioblastoma (GBM) remains lethal despite multimodal therapy, with median survival under 15 months. Immunotherapy has failed in over 100 clinical trials due to three fundamental barriers: inadequate immune priming in "cold" tumors, blood–brain barrier (BBB) exclusion of therapeutics, and profound local immunosuppression.

  • Updated Dec 23, 2025
  • TeX

🔬 First computational framework for p62/SQSTM1 condensate-mediated PD-L1 regulation | GPU-accelerated LLPS predictions | TCGA analysis (n=100) | Publication-ready (PLoS Comp Bio → Nature Comm) | Fast, Precise, Truthful

  • Updated Nov 8, 2025
  • Python

Improve this page

Add a description, image, and links to the cancer-immunotherapy topic page so that developers can more easily learn about it.

Curate this topic

Add this topic to your repo

To associate your repository with the cancer-immunotherapy topic, visit your repo's landing page and select "manage topics."

Learn more